Best Chinese Stocks To Add to Your Watchlist - October 14th

Key Points

• Seven Chinese stocks have been highlighted by MarketBeat, including Diageo, UP Fintech, and Regencell Bioscience, indicating strong trading volumes and potential investment opportunities.
• Chinese stocks represent a way for investors to gain exposure to China's economy, but they come with unique risks such as currency volatility and regulatory challenges.
• Companies like UP Fintech and Regencell Bioscience are focused on providing financial services and traditional medicine solutions respectively, catering to specific market needs in China.

Diageo, UP Fintech, Regencell Bioscience, Universe Pharmaceuticals, RBB Bancorp, Baiya International Group, and Taoping are the seven Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities of companies that are incorporated in or derive the bulk of their revenue from China and are traded on mainland Chinese exchanges (Shanghai and Shenzhen), in Hong Kong (H‑shares), or overseas as American Depositary Receipts (ADRs). For investors, they represent a way to gain exposure to China's economy but carry country-specific considerations like different listing rules, currency and regulatory risks, and potential political or market-volatility influences. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.

Read Our Latest Research Report on UPC

RBB Bancorp (RBB)

RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.

Read Our Latest Research Report on RBB

Baiya International Group (BIYA)

We, Baiya International Group Inc. (“Baiya”), are an offshore holding company incorporated in the Cayman Islands. We are not a Chinese operating company, but an offshore holding company incorporated in the Cayman Islands. As a holding company, we have no material operations and conduct all of our operations in China through the VIE, Shenzhen Gongwuyuan Network Technology Co., Ltd.

Read Our Latest Research Report on BIYA

Taoping (TAOP)

Taoping Inc. provides cloud-based platform, resource sharing, and big data solutions to the Chinese new media, education residential community management, and elevator Internet of Things (IoT) industries in the People's Republic of China. It operates through Cloud-Based Technology and Traditional Information Technology segments.

Read Our Latest Research Report on TAOP